Effects of self-management on chronic kidney disease: A meta-analysis

Mei Yu Lin, Megan F. Liu, Lan Fang Hsu, Pei Shan Tsai

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Background Self-management programs may facilitate the improvement of outcomes in medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. Studies on the effect of three self-management tasks have reported conflicting findings. In addition, systematic reviews are unavailable. Objective This study evaluated the effects of self-management programs on medical, role, and emotional management and health-related quality of life in chronic kidney disease. Design Meta-analysis of randomized controlled studies. Data sources The meta-analysis involved an online search of the English literature from PubMed, Cochrane, Web of Science, and CINAHL and the Chinese literature from the Airiti Library that were published from the inception of the websites until January 1, 2017. Review methods The meta-analysis was conducted to evaluate the effects of self-management on chronic kidney disease outcomes. Electronic databases were searched by using keywords: chronic kidney disease, end-stage renal disease, renal failure, dialysis, self-management, self-efficacy, empowerment, cognitive behavioral, and educational. The methodological quality of randomized controlled trials was assessed using the Cochrane Handbook. Data were analyzed using Comprehensive Meta-Analysis software 2.0. Results Eighteen randomized controlled trials met our inclusion criteria. The results revealed that the self-management program significantly enhanced the effects of self-management on outcomes of medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. The following Hedges’ g (effect size) values were obtained: (1) interdialytic weight gain, −0.36 (95% confidence interval, −0.60 to −0.12, p < 0.01); (2) self-efficacy, 0.57 (95% confidence interval, 0.18–0.96, p < 0.01); (3) anxiety, −0.95 (95% confidence interval, −1.65 to −0.25, p = 0.01); (4) depression, −0.63 (95% confidence interval, −0.85 to −0.41, p < 0.01) (5) health-related quality of life for the mental component of the SF-36, 0.71 (95% confidence interval, 0.45–0.97, p < 0.01); (6) the physical component of the SF-36, 0.61 (95% confidence interval, 0.35–0.86, p < 0.01); and (7) the Kidney Disease Quality of Life, 0.41 (95% confidence interval, 0.17–0.65, p < 0.01). Discussion This study revealed a small effect of self-management on interdialytic weight gain; medium effects on self-efficacy, depression, and health-related quality of life; and a large effect on anxiety. However, high-quality randomized controlled trial designs are required to confirm these results, although the existing evidence can guide clinical practitioners and health policy makers.

Original languageEnglish
Pages (from-to)128-137
Number of pages10
JournalInternational Journal of Nursing Studies
Volume74
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Self Care
Chronic Renal Insufficiency
Meta-Analysis
Confidence Intervals
Quality of Life
Self Efficacy
Randomized Controlled Trials
Weight Gain
Anxiety
Depression
Literature
Information Storage and Retrieval
Kidney Diseases
Health Policy
Administrative Personnel
PubMed
Libraries
Chronic Kidney Failure
Renal Insufficiency
Renal Dialysis

Keywords

  • Chronic kidney disease
  • Health-related quality of life
  • Interdialytic weight gain
  • Self-efficacy
  • Self-management

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Effects of self-management on chronic kidney disease : A meta-analysis. / Lin, Mei Yu; Liu, Megan F.; Hsu, Lan Fang; Tsai, Pei Shan.

In: International Journal of Nursing Studies, Vol. 74, 01.09.2017, p. 128-137.

Research output: Contribution to journalReview article

@article{bd360c09d7b84dfaa2b4dbcbe102d772,
title = "Effects of self-management on chronic kidney disease: A meta-analysis",
abstract = "Background Self-management programs may facilitate the improvement of outcomes in medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. Studies on the effect of three self-management tasks have reported conflicting findings. In addition, systematic reviews are unavailable. Objective This study evaluated the effects of self-management programs on medical, role, and emotional management and health-related quality of life in chronic kidney disease. Design Meta-analysis of randomized controlled studies. Data sources The meta-analysis involved an online search of the English literature from PubMed, Cochrane, Web of Science, and CINAHL and the Chinese literature from the Airiti Library that were published from the inception of the websites until January 1, 2017. Review methods The meta-analysis was conducted to evaluate the effects of self-management on chronic kidney disease outcomes. Electronic databases were searched by using keywords: chronic kidney disease, end-stage renal disease, renal failure, dialysis, self-management, self-efficacy, empowerment, cognitive behavioral, and educational. The methodological quality of randomized controlled trials was assessed using the Cochrane Handbook. Data were analyzed using Comprehensive Meta-Analysis software 2.0. Results Eighteen randomized controlled trials met our inclusion criteria. The results revealed that the self-management program significantly enhanced the effects of self-management on outcomes of medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. The following Hedges’ g (effect size) values were obtained: (1) interdialytic weight gain, −0.36 (95{\%} confidence interval, −0.60 to −0.12, p < 0.01); (2) self-efficacy, 0.57 (95{\%} confidence interval, 0.18–0.96, p < 0.01); (3) anxiety, −0.95 (95{\%} confidence interval, −1.65 to −0.25, p = 0.01); (4) depression, −0.63 (95{\%} confidence interval, −0.85 to −0.41, p < 0.01) (5) health-related quality of life for the mental component of the SF-36, 0.71 (95{\%} confidence interval, 0.45–0.97, p < 0.01); (6) the physical component of the SF-36, 0.61 (95{\%} confidence interval, 0.35–0.86, p < 0.01); and (7) the Kidney Disease Quality of Life, 0.41 (95{\%} confidence interval, 0.17–0.65, p < 0.01). Discussion This study revealed a small effect of self-management on interdialytic weight gain; medium effects on self-efficacy, depression, and health-related quality of life; and a large effect on anxiety. However, high-quality randomized controlled trial designs are required to confirm these results, although the existing evidence can guide clinical practitioners and health policy makers.",
keywords = "Chronic kidney disease, Health-related quality of life, Interdialytic weight gain, Self-efficacy, Self-management",
author = "Lin, {Mei Yu} and Liu, {Megan F.} and Hsu, {Lan Fang} and Tsai, {Pei Shan}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.ijnurstu.2017.06.008",
language = "English",
volume = "74",
pages = "128--137",
journal = "International Journal of Nursing Studies",
issn = "0020-7489",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Effects of self-management on chronic kidney disease

T2 - A meta-analysis

AU - Lin, Mei Yu

AU - Liu, Megan F.

AU - Hsu, Lan Fang

AU - Tsai, Pei Shan

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Background Self-management programs may facilitate the improvement of outcomes in medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. Studies on the effect of three self-management tasks have reported conflicting findings. In addition, systematic reviews are unavailable. Objective This study evaluated the effects of self-management programs on medical, role, and emotional management and health-related quality of life in chronic kidney disease. Design Meta-analysis of randomized controlled studies. Data sources The meta-analysis involved an online search of the English literature from PubMed, Cochrane, Web of Science, and CINAHL and the Chinese literature from the Airiti Library that were published from the inception of the websites until January 1, 2017. Review methods The meta-analysis was conducted to evaluate the effects of self-management on chronic kidney disease outcomes. Electronic databases were searched by using keywords: chronic kidney disease, end-stage renal disease, renal failure, dialysis, self-management, self-efficacy, empowerment, cognitive behavioral, and educational. The methodological quality of randomized controlled trials was assessed using the Cochrane Handbook. Data were analyzed using Comprehensive Meta-Analysis software 2.0. Results Eighteen randomized controlled trials met our inclusion criteria. The results revealed that the self-management program significantly enhanced the effects of self-management on outcomes of medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. The following Hedges’ g (effect size) values were obtained: (1) interdialytic weight gain, −0.36 (95% confidence interval, −0.60 to −0.12, p < 0.01); (2) self-efficacy, 0.57 (95% confidence interval, 0.18–0.96, p < 0.01); (3) anxiety, −0.95 (95% confidence interval, −1.65 to −0.25, p = 0.01); (4) depression, −0.63 (95% confidence interval, −0.85 to −0.41, p < 0.01) (5) health-related quality of life for the mental component of the SF-36, 0.71 (95% confidence interval, 0.45–0.97, p < 0.01); (6) the physical component of the SF-36, 0.61 (95% confidence interval, 0.35–0.86, p < 0.01); and (7) the Kidney Disease Quality of Life, 0.41 (95% confidence interval, 0.17–0.65, p < 0.01). Discussion This study revealed a small effect of self-management on interdialytic weight gain; medium effects on self-efficacy, depression, and health-related quality of life; and a large effect on anxiety. However, high-quality randomized controlled trial designs are required to confirm these results, although the existing evidence can guide clinical practitioners and health policy makers.

AB - Background Self-management programs may facilitate the improvement of outcomes in medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. Studies on the effect of three self-management tasks have reported conflicting findings. In addition, systematic reviews are unavailable. Objective This study evaluated the effects of self-management programs on medical, role, and emotional management and health-related quality of life in chronic kidney disease. Design Meta-analysis of randomized controlled studies. Data sources The meta-analysis involved an online search of the English literature from PubMed, Cochrane, Web of Science, and CINAHL and the Chinese literature from the Airiti Library that were published from the inception of the websites until January 1, 2017. Review methods The meta-analysis was conducted to evaluate the effects of self-management on chronic kidney disease outcomes. Electronic databases were searched by using keywords: chronic kidney disease, end-stage renal disease, renal failure, dialysis, self-management, self-efficacy, empowerment, cognitive behavioral, and educational. The methodological quality of randomized controlled trials was assessed using the Cochrane Handbook. Data were analyzed using Comprehensive Meta-Analysis software 2.0. Results Eighteen randomized controlled trials met our inclusion criteria. The results revealed that the self-management program significantly enhanced the effects of self-management on outcomes of medical, role, and emotional management and health-related quality of life in patients with chronic kidney disease. The following Hedges’ g (effect size) values were obtained: (1) interdialytic weight gain, −0.36 (95% confidence interval, −0.60 to −0.12, p < 0.01); (2) self-efficacy, 0.57 (95% confidence interval, 0.18–0.96, p < 0.01); (3) anxiety, −0.95 (95% confidence interval, −1.65 to −0.25, p = 0.01); (4) depression, −0.63 (95% confidence interval, −0.85 to −0.41, p < 0.01) (5) health-related quality of life for the mental component of the SF-36, 0.71 (95% confidence interval, 0.45–0.97, p < 0.01); (6) the physical component of the SF-36, 0.61 (95% confidence interval, 0.35–0.86, p < 0.01); and (7) the Kidney Disease Quality of Life, 0.41 (95% confidence interval, 0.17–0.65, p < 0.01). Discussion This study revealed a small effect of self-management on interdialytic weight gain; medium effects on self-efficacy, depression, and health-related quality of life; and a large effect on anxiety. However, high-quality randomized controlled trial designs are required to confirm these results, although the existing evidence can guide clinical practitioners and health policy makers.

KW - Chronic kidney disease

KW - Health-related quality of life

KW - Interdialytic weight gain

KW - Self-efficacy

KW - Self-management

UR - http://www.scopus.com/inward/record.url?scp=85021728751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021728751&partnerID=8YFLogxK

U2 - 10.1016/j.ijnurstu.2017.06.008

DO - 10.1016/j.ijnurstu.2017.06.008

M3 - Review article

C2 - 28689160

AN - SCOPUS:85021728751

VL - 74

SP - 128

EP - 137

JO - International Journal of Nursing Studies

JF - International Journal of Nursing Studies

SN - 0020-7489

ER -